Contract Award: Celltrion USA Inc. (Jersey City, New Jersey (SPE2DE-21-D-0052) – $626,400,000);

Celltrion USA Inc., Jersey City, New Jersey (SPE2DE-21-D-0052, $626,400,000); and Abbott Corp., Orlando, Florida (SPE2DE-21-D-0053, $554,400,000), have each been awarded an indefinite-delivery/indefinite-quantity contract under solicitation SPE2DE-21-R-0010 for Point of Care rapid antigen COVID-19 test kits. These were competitive acquisitions with seven responses received. These are one-year contracts with no option periods. Locations of performance are throughout the U.S., with a Sept. 16, 2022, ordering period end date. Using customer is Department of Health and Human Services. Type of appropriation is fiscal 2021 through 2022 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-21-D-0052). (Awarded Sept. 17, 2021)